MRC1 and Leigh syndrome: This observation emphasizes that diagnosis of a first primary LS‐associated cancer is an important clinical indicator to prioritize MMR gene testing and could enable timely identification of MMR gene pathogenic variant carriers for implementation of appropriate cancer risk reduction strategies to prevent second primary cancers.